Drug intelligence / Profile preview

leucine + sildenafil

Development stage
Phase 2
Lead developer
NuSirt Biopharma
Modality
Small Molecules, Peptides
Administration
Oral
01

Overview

Leucine + sildenafil is a fixed-dose combination of the amino acid L-leucine and the phosphodiesterase type 5 (PDE5) inhibitor sildenafil. This investigational therapy was developed to target metabolic diseases such as obesity by modulating energy metabolism. The mechanism involves allosteric activation of sirtuin 1 (SIRT1) by leucine and inhibition of PDE5A by sildenafil, which together are thought to synergistically activate AMP-activated protein kinase (AMPK), SIRT1, and nitric oxide pathways. These pathways play key roles in regulating energy expenditure and fat metabolism. Clinical studies have evaluated this combination for its effects on body weight reduction in obese individuals[1][3][4].

Other names
Leu SilSildenafil/leucineleucine/sildenafil combination therapy
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)PDE5 (Phosphodiesterase 5A)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)NOS3 (eNOS)

Beyond the preview

Go deeper on leucine + sildenafil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on leucine + sildenafil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call